Clinical Trial Update: Clinic Registry Study of Optic Neuromyelitis Spectrum Disease in China

View source ↗

Summary

Clinical registry study update on Neuromyelitis Optica Spectrum Disorder in China, sponsored by Beijing Tongren Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica Spectrum Disorder

Snippet

Sponsor: Beijing Tongren Hospital | Conditions: NMO Spectrum Disorder;Registry Study | Status: UNKNOWN